Moody's report confirms European CDO growth

Ratings agency Moody’s Investors Service said the European collateralised debt obligation (CDO) market grew by 46% in the first half of 2002, compared with the corresponding period of last year. Moody’s rated 72 CDO transactions in the first half of the year with a total volume of €74.4 billion, compared with 49 deals in first-half 2001 totalling €48.7 billion.

Moody’s said it expected the growth levels to be sustained over the second half of 2002, with a continued preponderance of synthetic CDOs over cash structures. Synthetic deals accounted for 92% of the volume in the first half of this year.

The agency noted that static synthetic transactions are progressively being replaced by managed synthetic deals.

Moody's added that it expects more esoteric CDOs to emerge, containing portfolios such as asset-backed security re-securitisations, hedge funds, private equity and macro-hedge transactions backed by highly diversified assets.

Moody’s also said that, despite the huge growth in volumes, CDOs had a difficult year in terms of ratings actions with 152 tranches downgraded compared with three upgrades. “A significant proportion of the downgrades are attributable to static synthetic deals, many of which share similar names in their portfolios. This means that one major credit event can have an impact on several transactions,” said the report.

The spate of downgrades is likely to persist, said Moody’s, as the credit markets continue to experience volatile conditions.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here